GLP-1 Cardiovascular Benefits
Mapping the weight-independent heart protection mechanism
"What is the magnitude and mechanism of cardiovascular benefit from GLP-1 receptor agonists independent of weight loss?"
- You have hypertension (from HealthID)
- Family history of heart disease
HealthID Data Shares
3,421 / 3,500
98% · patients
CV Panels Completed
892 / 1,000
89% · tests
Research Funding
487,000 / 500,000
97% · USD
Expert Reviews
67 / 50
100% · reviews
Three Ways to Contribute
Share Your Cardiovascular Data
Have heart-related labs or take GLP-1 drugs? Your data strengthens the evidence.
Requirements
Data contributor · Revenue share from $245K generated
Get the CV Panel
Comprehensive cardiovascular biomarker panel to contribute to the evidence base.
Cardiovascular Panel
Comprehensive cardiovascular biomarker panel including hs-CRP, NT-proBNP, and lipid subfractions
$150
Test contributor · Revenue share · Free result analysis
Fund the Research
This campaign is 97% funded. Help us reach the finish line.
Proven.dev Provenance Chain
Cryptographic trail from contribution → finding → revenue
HealthID data shares, lab results, medication histories — each cryptographically hashed at ingestion
Cardiovascular Panel results verified by CLIA-certified labs, timestamped and chained to contributor identity
AI synthesis engine processes all data, cross-references literature, and generates findings — each version immutably recorded
Adversarial AI council evaluates findings — challenges methodology, checks for bias, verifies reproducibility
Findings licensed to pharmaceutical partners. Revenue distributed proportionally to all contributors based on provenance chain position.
Data Contributors
$122K
50% share
Test Contributors
$73K
30% share
Funders
$49K
20% share
People Control Their Health Destiny
Consumers own their data, contribute voluntarily, and never pay. Ever.
Contributors Share in the Value They Create
When findings generate revenue, the people whose data and expertise made it possible get paid. Tracked through cryptographic provenance.
The People Direct the Science
Profits fund a democratic grant pool. Patients vote on what gets researched.
President — The People
Truth above all else.
Colby Fox — Creator, but not owner.
Campaign Updates
Real-world outcomes data from 3,421 patients confirms the weight-independent cardiovascular mechanism. Revenue distribution to contributors initiated.
Recent Contributors
Anonymous shared cardiovascular data
1 hour ago
CardioResearch Foundation donated $5,000
3 hours ago
Your Chain Position
Your contributions are cryptographically recorded. Scroll up to see the full provenance chain visualization.
See the full scientific analysis, version history, council evaluations, and blast radius for this question.
Open queryGLP-1 Cardiovascular Benefits
Mapping the weight-independent heart protection mechanism
"What is the magnitude and mechanism of cardiovascular benefit from GLP-1 receptor agonists independent of weight loss?"
- You have hypertension (from HealthID)
- Family history of heart disease
HealthID Data Shares
3,421 / 3,500
98% · patients
CV Panels Completed
892 / 1,000
89% · tests
Research Funding
487,000 / 500,000
97% · USD
Expert Reviews
67 / 50
100% · reviews
Three Ways to Contribute
Share Your Cardiovascular Data
Have heart-related labs or take GLP-1 drugs? Your data strengthens the evidence.
Requirements
Data contributor · Revenue share from $245K generated
Get the CV Panel
Comprehensive cardiovascular biomarker panel to contribute to the evidence base.
Cardiovascular Panel
Comprehensive cardiovascular biomarker panel including hs-CRP, NT-proBNP, and lipid subfractions
$150
Test contributor · Revenue share · Free result analysis
Fund the Research
This campaign is 97% funded. Help us reach the finish line.
Proven.dev Provenance Chain
Cryptographic trail from contribution → finding → revenue
HealthID data shares, lab results, medication histories — each cryptographically hashed at ingestion
Cardiovascular Panel results verified by CLIA-certified labs, timestamped and chained to contributor identity
AI synthesis engine processes all data, cross-references literature, and generates findings — each version immutably recorded
Adversarial AI council evaluates findings — challenges methodology, checks for bias, verifies reproducibility
Findings licensed to pharmaceutical partners. Revenue distributed proportionally to all contributors based on provenance chain position.
Data Contributors
$122K
50% share
Test Contributors
$73K
30% share
Funders
$49K
20% share
People Control Their Health Destiny
Consumers own their data, contribute voluntarily, and never pay. Ever.
Contributors Share in the Value They Create
When findings generate revenue, the people whose data and expertise made it possible get paid. Tracked through cryptographic provenance.
The People Direct the Science
Profits fund a democratic grant pool. Patients vote on what gets researched.
President — The People
Truth above all else.
Colby Fox — Creator, but not owner.
Campaign Updates
Real-world outcomes data from 3,421 patients confirms the weight-independent cardiovascular mechanism. Revenue distribution to contributors initiated.
Recent Contributors
Anonymous shared cardiovascular data
1 hour ago
CardioResearch Foundation donated $5,000
3 hours ago
Your Chain Position
Your contributions are cryptographically recorded. Scroll up to see the full provenance chain visualization.
See the full scientific analysis, version history, council evaluations, and blast radius for this question.
Open query